跳至主要内容
临床试验/ITMCTR2200006036
ITMCTR2200006036招募中4 期

A randomized controlled prospective study of Reyanning mixture in the treatment of mild novel coronavirus pneumonia (COVID-19)

Jiujiang Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
1 至 80(—)
性别
All

入选标准

  • In accordance with the Novel Coronavirus Diagnosis and Treatment Protocol (Trial Version 9) issued by the National Health Commission Diagnosis of mild COVID-19; Signed informed consent.

排除标准

  • 1. Patients with normal, severe or critical type of NCOV infection; 2. Other lung diseases; 3. Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system; 4. Patients with basic lung diseases such as severe interstitial lung lesions confirmed by chest CT; 5. People who cannot cooperate in mental state, suffer from mental diseases, cannot control themselves and cannot express themselves clearly; 6. Allergic constitution (such as allergic to two or more drugs or food) or allergic history of this product and conventional treatment drugs; 7. Pregnant or lactating women.

研究者

相似试验